Albutegrin

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameAlbutegrin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionOsteoclasts inhibitorsTumor necrosis factor ligand superfamily member 11 inhibitors
TargetsTumor necrosis factor ligand superfamily member 11
Therapy Area/IndicationsOsteoporosisMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Genome Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Genome Sciences Inc
Active IndicationsN/A
Inactive IndicationsOsteoporosisMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A